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Methods
We utilized a retrospective chart review to identify 101 patients who since the establishment of our SILS program underwent either robotic surgery or SILS for the management of endometrial cancer. Statistical analyses and plots were generated using SAS® software. Independent samples t-tests, fisher's exact tests, and simple linear regression were used to compare patient characteristics, operating times, operative complications, blood loss, conversion rates, and pathological findings across the two groups.
Results
101 patients were included. Sixty-seven patients underwent robotic surgery (66.3%), while thirty-four patients underwent SILS (33.7%). SILS patients had a significantly lower BMI, grade of disease, stage, and fewer co-morbidities than those of the robot group. There were no significant differences in length of hospital stay, blood loss, operative complication rates, conversion rates, or yield of pelvic and para-aortic lymph nodes when comparing the two groups. Operative time was significantly decreased in the SILS group, while both SILS and robotic surgery appeared to have a similar learning curve with consistent improvement in operative time across the study period. 
Conclusions

